Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm

AIDS Research and Human Retroviruses

Volumn 16, Issue 1, 2000, Pages 67-76

  Jin, Xia ^a   Roberts, C G P ^a   Nixon, D F ^a   Safrit, J T ^b   Zhang, L Q ^a   Huang, Y X ^a   Bhardwaj, N ^a   Jesdale, B ^c   DeGroot, A S ^c   Koup, R A ^a,d  

^a ROCKEFELLER UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; EPITOPE; HLA B7 ANTIGEN; VIRUS DNA;

ALGORITHM; ARTICLE; CASE REPORT; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS CELL TRANSFORMATION;

ALGORITHMS; COMPUTER SIMULATION; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HLA-B7 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033986385     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309610     Document Type: Article

References (40)

1. 1. Borrow P, Lewicki H, Hahn BH, Shaw GM, and Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110.
2. 2. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, and Walker BD: Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol 1996;156:2616-2623.
3. 3. Klein MR, van Baalen CA, Holwerda AM, KerkhofGarde SR, Bende Rj, Keet IPM, Eeftinck-Schattenkerk JKM, Osterhaus ADME, Schuitemaker H, and Miedema F: Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372.
4. 4. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, and Ho DD: Temporal association of cellular immune response with the initial control of viremia in primary HIV-1 syndrome. J Virol 1994;68:4650-4655.
5. 5. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, and Ho DD: Dramatic rise in plasma viremia after CD8+ T-cell depletion in SIV-infected macaques. J Exp Med 1999;189:991-998.
6. 6. Schmitz JE, Kuroda MJ, Santra S, Dalesandro M, Ghrayeb J, Montefiori DC, Tenner-Racz K, Racz P, Rieber E, Letvin NL, and Reimann KA: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283:857-860.
7. 7. Goulder PJR, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, and Rowland Jones S: Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS. Nature Med 1997;3:212.
8. 8. Wolinsky SM, Korber BTM, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT, and Koup RA: Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 1996;272:537-542.
9. 9. Dyer WB, Ogg GS, Demoitie M-A, Jin X, Geczy AF, Rowland-Jones S, McMichael AJ, Nixon DF, and Sullivan JS: Strong human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol 1999;73:436-443.
10. 10. Gabriel EM, Roberts CGP, Berzofsky JA, and DeGroot AS: Two novel T cell epitope prediction algorithms based on MHC-binding motifs: Comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine 1995;13:581-591.
11. 11. DeGroot AS, Jesdale BM, Szu E, Schafer JR, Chicz RM, and Deocampo G: An interactive Web site providing major histocompatibility ligand predictions: Application to HIV research. AIDS Res Hum Retroviruses 1997;13:529-531.
12. 12. Steinman RM: The dendritic cells system and its role in immunogenicity. Annu Rev Immunol 1991;9:271.
13. 13. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature (London) 1998;392:245-252.
14. 14. Bender A, Sapp M, Schuler G, Steinman RM, and Bhardwaj N: Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 1996;196:121-135.
15. 15. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, and Schuler G: Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-151.
16. 16. Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, and Steinman RM: Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T-cells. J Clin Invest 1994;94:797-807.
17. 17. Sapp M, Engelmayer J, Larsson M, Granelli-Piperno A, Steinman RM, and Bhardwaj N: Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses. Immunol Lett 1999;66:121-128.
18. 18. Boczkowski D, Nair SK, Snyder D, and Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996;184:465-472.
19. 19. van Elsas A, van der Burg SH, van der Minne CE, Borghi M, Mourer JS, Melief CJM, and Schrier PI: Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stable HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. Eur J Immunol 1996;26:1683-1689.
20. 20. Dupuis M, Peshwa MV, Benike C, Kundu SK, Engleman EG, Van Schooten WCA, and Merigan TC: Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals. AIDS Res Hum Retroviruses 1997;13:33-39.
21. 21. Bender A, Bui LK, Feldman MA, Larsson M, and Bhardwaj N: Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med 1995; 182:1663-1671.
22. 22. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332: 201-208.
23. 23. Huang Y, Zhang L, and Ho DD: Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1995;69:93-100.
24. 24. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, and Ho DD: Genotypic and phenotypic characterization of long terminal repeat from long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1997;71:5608-5613.
25. 25. Connor R, Paxton WA, Sheridan KE, and Koup RA: Macrophages and CD4+ T-lymphocytes from two multiply exposed uninfected individuals resist infection with primary NSI isolates of human immunodeficiency virus type 1. J Virol 1996;70:8758-8764.
26. 26. Huang Y, Zhang L, and Ho DD: Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology 1998;240:36-49.
27. 27. Gallimore A, Dumrese T, Hangartner H, Zinkernagel RM, and Rammensee HG: Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med 1998;187:1647-1657.
28. 28. Carmichael A, Jin X, Sissons P, and Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein Barr virus in late disease. J Exp Med 1993;177:249-256.
29. 29. Ogg GS, Jin X, Bonhoeffe S, Dunbar RP, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, and McMichael AJ: Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-2106.
30. 30. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard J, Bangham CRM, Rizza CR, and McMichael AJ: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (London) 1991;354:453-459.
31. 31. Klenerman P, Rowland-Jones S, McAdams S, Edwards S, Daenke S, Lalloo D, Koppe B, Rosenberg W, Boyd D, Edwards A, Giangrande P, Phillips RE, and McMichael AJ: Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants. Nature (London) 1994;369:403-407.
32. 32. Rammensee HG, Friede T, and Stevanovic S: MHC ligands and peptide motifs: First listing. Immunogenetics 1995;41:178-228.
33. 33. Pogue RR, Eron F, Frelinger JA, and Matsui M: Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus Pol peptide increases complex stability and in vitro immunogenicity. Proc Natl Acad Sci USA 1995;92:8166-8170.
34. 34. Madden DR, Garboczi DN, and Wiley DC: The antigenic identity of peptide-MHC complexes: A comparison of the conformation of five viral peptides presented by HLA-A2. Cell 1993;75:693-708.
35. 35. Madden DR, Gorga JC, Strominger JL, and Wiley DC: The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature (London) 1991;353:321-325.
36. 36. Betts MR, Krowka J, Santamaria C, Balsamo K, Gao F, Mulundu G, Luo C, N'Gandu N, Sheppard H, Hahn BH, Allen S, and Frelinger JA: Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte response in HIV-infected Zambians. J Virol 1997;71:8908-8911.
37. 37. Cao H, Kanki P, Sankale JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, and Walker BD: Cytotoxic T lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development. J Virol 1997;71:8615-8623.
38. 38. Pikora CA, Sullivan JL, Panicali D, and Luzuriaga K: Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants. J Exp Med 1997;185:1153-1161.
39. 39. Carmichael A, Jin X, and Sissons P: Analysis of the human env-specific cytotoxic T lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: Low prevalence of broadly cross-reactive Env-specific CTL. J Virol 1996;70:8468-8476.
40. 40. Korber BTM, Walker BD, Moore JP, Myers G, Brander C, Koup R, and Haynes BF: HIV Molecular Immunology Database. Los Alamos National Laboratory, Los Alamos, New Mexico, 1996.